The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
- 30 May 2012
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 30, B87-B97
- https://doi.org/10.1016/j.vaccine.2012.01.033
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AI054544, AI084048, AI32725)
This publication has 109 references indexed in Scilit:
- Capsular polysaccharide vaccine for Group BNeisseria meningitidis,Escherichia coliK1, andPasteurella haemolyticaA2Proceedings of the National Academy of Sciences of the United States of America, 2011
- Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeysVaccine, 2011
- Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigenVaccine, 2011
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccinesProceedings of the National Academy of Sciences of the United States of America, 2010
- Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humansProceedings of the National Academy of Sciences of the United States of America, 2010
- Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine developmentThe Lancet Infectious Diseases, 2009
- Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidisVaccine, 2009
- Meningococcal carriage and disease—Population biology and evolutionVaccine, 2009
- Neisseria meningitidis recruits factor H using protein mimicry of host carbohydratesNature, 2009
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences of the United States of America, 2006